Length
1 hour
CE Credit
1.0 unit
Recorded
February 20, 2026
The goal of this continuing education program is to strengthen psychologists’ ability to identify when a medication review or deprescribing referral may be clinically appropriate and to support clients during medication changes. Building on doctoral-level training, this program focuses on differentiating medication side effects, withdrawal symptoms, and symptom recurrence; applying therapeutic supports during medication transitions; and collaborating effectively with prescribing providers as part of coordinated, evidence-based mental health care.
There are several ways to learn from this training. You can either watch the recording for free or take the self-paced course for CE credit. We also have the slides available to download.
(Free) You can watch the full recording of this training for free on our YouTube Channel. This is perfect if you’re not seeking CE credit or would like to preview the training before taking the course.
($22) You can receive 1 hour of self-paced, asynchronous CE credit for this training.
UCEBT is approved by the American Psychological Association to sponsor continuing education for psychologists. UCEBT maintains responsibility for this program and its content.
Additionally, this presentation is approved for 1 hours of home-study CE credit through NASW-UT, UAMFT, and UMHCA.
Follow along with the recording by downloading the presentation slides personal use.
However, please note that no part of the materials available through the Utah Center for Evidence Based Treatment may be copied, photocopied, reproduced, translated or reduced to any electronic medium or machine-readable form, in whole or in part, without prior written consent of the presenter and creator of the presentation. Contact info@ucebt.com for questions.
Mental health professionals frequently work with clients who are prescribed for psychiatric medications and may observe changes related to medication side effects, withdrawal experiences, or symptom recurrence over time. Within collaborative mental health care, therapists play an important role in identifying when a medication review or deprescribing referral may be clinically appropriate, as well as in supporting clients during medication changes.
In this session, Nathaniel Barusch, M.D. will review key clinical indicators that suggest the need for medication reevaluation and provide guidance on differentiating medication side effects, withdrawal symptoms, and symptom recurrence. The presentation will address common considerations related to antidepressants, benzodiazepines, and antipsychotics, and outline therapeutic supports psychologists can offer during medication transitions. The session will also emphasize effective collaboration and communication with prescribing providers as part of coordinated, evidence-based care.
Learning Objectives:
Compare medication side effects, withdrawal symptoms, and symptom recurrence.
Identify indicators that a client may benefit from a medication review or deprescribing referral.
Apply therapeutic supports during medication changes for antidepressants, benzodiazepine, and antipsychotics.
Demonstrate effective collaboration with prescribing providers.
Dr. Nathaniel Barusch has practiced psychiatry in a variety of settings from Wilderness therapy programs in Utah to crisis teams in New Zealand. In addition to his psychiatry training at UC-Davis he has advanced training in integrative psychiatry and psychedelic assisted psychotherapy.
Andrade C. Antipsychotic Medication Continuation vs Taper and Discontinuation in Patients With Schizophrenia and Other Nonaffective Psychotic Disorders. J Clin Psychiatry. 2024 May 15;85(2):24f15363. doi: 10.4088/JCP.24f15363. PMID: 38767930.
Harding SL, Ellis KA, Boisseau J, Petreca V. Psychiatric Deprescribing: A Narrative Review. J Am Psychiatr Nurses Assoc. 2024 Jul-Aug;30(4):810-818. doi: 10.1177/10783903231185353. Epub 2023 Jul 1. PMID: 37392084.
Horowitz MA, Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry. 2019 Jun;6(6):538-546. doi: 10.1016/S2215-0366(19)30032-X. Epub 2019 Mar 5. PMID: 30850328.
Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, Holbrook A, Boyd C, Swenson R, Ma A, Farrell B. Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline. Can Fam Physician. 2018 May;64(5):339-351. PMID: 29760253; PMCID: PMC5951648.
Stimpfl JN, Walkup JT, Robb AS, Alford AE, Stahl SM, McCracken JT, Stancil SL, Ramsey LB, Emslie GJ, Strawn JR. Deprescribing Antidepressants in Children and Adolescents: A Systematic Review of Discontinuation Approaches, Cross-Titration, and Withdrawal Symptoms. J Child Adolesc Psychopharmacol. 2025 Feb;35(1):3-22. doi: 10.1089/cap.2024.0099. Epub 2024 Oct 29. PMID: 39469761; PMCID: PMC11971562.
We have provided expert virtual trainings and self-paced courses for
continuing education credit since 2020 on a variety of evidence-based topics.
The unique mission of UCEBT is to improve the quality of mental health care by enhancing access to comprehensive evidence-based treatments, evaluations, and testing.
Quick Links
Visit Us
Business Address:
170 S 1000 E, Suite 201
Salt Lake City, UT
84102
Business Hours:
Monday
Tuesday
Wednesday
Thursday
Friday
Saturday – Sunday
9:00 am – 7:00 pm
9:00 am – 7:00 pm
9:00 am – 7:00 pm
9:00 am – 6:00 pm
9:00 am – 5:00 pm
Closed
© 2024 Utah Center for Evidenced Based Treatment. Powered by Big Red Jelly.
